Anthony J. Dalby

6.4k total citations · 3 hit papers
34 papers, 2.6k citations indexed

About

Anthony J. Dalby is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Anthony J. Dalby has authored 34 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 5 papers in Internal Medicine. Recurrent topics in Anthony J. Dalby's work include Acute Myocardial Infarction Research (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Anthony J. Dalby is often cited by papers focused on Acute Myocardial Infarction Research (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Anthony J. Dalby collaborates with scholars based in United States, United Kingdom and France. Anthony J. Dalby's co-authors include Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott, Marc P. Bonaca, David A. Morrow, Elliott M. Antman, Benjamin M. Scirica, José Carlos Nicolau, Ramón Corbalán and Dominick J. Angiolillo and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anthony J. Dalby

34 papers receiving 2.5k citations

Hit Papers

Vorapaxar in the Secondary Prevention of Atherothrombotic... 2008 2026 2014 2020 2012 2008 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
    2012 656 citations David A. Morrow, Eugene Braunwald et al. New England Journal of Medicine profile →
  2. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
    2008 498 citations Stephen D. Wiviott, Eugene Braunwald et al. Circulation profile →
  3. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
    2016 249 citations Marc P. Bonaca, Deepak L. Bhatt et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony J. Dalby United States 19 2.2k 1.1k 511 295 256 34 2.6k
Edward T.A. Fry United States 14 2.5k 1.2× 1.5k 1.4× 703 1.4× 146 0.5× 257 1.0× 40 2.8k
David J. Moliterno United States 32 2.5k 1.2× 1.1k 1.0× 630 1.2× 180 0.6× 468 1.8× 100 3.4k
Piera Angelica Merlini Italy 27 1.7k 0.8× 978 0.9× 368 0.7× 159 0.5× 372 1.5× 76 2.6k
Jean‐Paul R. Herrman Netherlands 14 2.0k 0.9× 1.2k 1.1× 553 1.1× 97 0.3× 382 1.5× 21 2.5k
Christian Valina Germany 19 1.9k 0.9× 1.5k 1.3× 393 0.8× 318 1.1× 268 1.0× 53 2.5k
Jacques Quilici France 25 2.5k 1.2× 1.3k 1.2× 743 1.5× 319 1.1× 91 0.4× 70 2.8k
George Kassimis Greece 19 1.3k 0.6× 853 0.8× 210 0.4× 147 0.5× 288 1.1× 110 1.6k
Bernardo Stein United States 18 1.5k 0.7× 1.3k 1.2× 132 0.3× 288 1.0× 499 1.9× 32 2.2k
Frederic Kontny Norway 17 1.6k 0.7× 895 0.8× 330 0.6× 127 0.4× 421 1.6× 49 1.9k
Mattía Galli Italy 22 1.4k 0.7× 689 0.6× 296 0.6× 149 0.5× 240 0.9× 138 1.9k

Countries citing papers authored by Anthony J. Dalby

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Dalby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Dalby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Dalby more than expected).

Fields of papers citing papers by Anthony J. Dalby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Dalby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Dalby. The network helps show where Anthony J. Dalby may publish in the future.

Co-authorship network of co-authors of Anthony J. Dalby

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Dalby. A scholar is included among the top collaborators of Anthony J. Dalby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Dalby. Anthony J. Dalby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furtado, Remo H.M., Itamar Raz, Erica L. Goodrich, et al.. (2022). Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Circulation. 145(21). 1581–1591. 19 indexed citations
2.
Lópes, Renato D., Patrícia O. Guimarães, Gregory G. Schwartz, et al.. (2022). Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial. The American Journal of Medicine. 135(7). 915–918. 4 indexed citations
3.
4.
Bohula, Erin A., Stephen D. Wiviott, Robert P. Giugliano, et al.. (2017). Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 136(25). 2440–2450. 82 indexed citations
5.
Dalby, Anthony J., Shmuel Gottlieb, Derek D. Cyr, et al.. (2017). Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization. American Heart Journal. 188. 156–166. 8 indexed citations
6.
Bonaca, Marc P., Deepak L. Bhatt, Robert F. Storey, et al.. (2016). Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology. 67(23). 2719–2728. 249 indexed citations breakdown →
7.
Eisen, Alon, Christian T. Ruff, Francesco Nordio, et al.. (2016). SUDDEN CARDIAC DEATH IN 21,105 PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ENGAGE AF- TIMI 48 TRIAL. Journal of the American College of Cardiology. 67(13). 789–789. 5 indexed citations
8.
Magnani, Giulia, Marc P. Bonaca, Eugene Braunwald, et al.. (2015). Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States. Journal of the American Heart Association. 4(3). e001505–e001505. 56 indexed citations
9.
Montalescot, Gilles, David Brieger, Anthony J. Dalby, Seung‐Jung Park, & Roxana Mehran. (2015). Duration of Dual Antiplatelet Therapy After Coronary Stenting. Journal of the American College of Cardiology. 66(7). 832–847. 78 indexed citations
10.
Dalby, Anthony J. & Lewis J. Levien. (2015). Spontaneous coronary artery dissection associated with fibromuscular dysplasia: case report. Cardiovascular journal of South Africa. 26(2). 86–90. 1 indexed citations
11.
Dalby, Anthony J., et al.. (2013). Warfarin in non-valvular atrial fibrillation. South African Medical Journal. 103(12). 901–901. 8 indexed citations
12.
Giraldez, Roberto R., Robert M. Clare, Renato D. Lópes, et al.. (2013). Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome. American Heart Journal. 165(6). 918–925.e2. 78 indexed citations
13.
Klutstein, Marc, Cynthia M. Westerhout, Paul W. Armstrong, et al.. (2013). Radial versus femoral access, bleeding and ischemic events in patients with non–ST-segment elevation acute coronary syndrome managed with an invasive strategy. American Heart Journal. 165(4). 583–590.e1. 14 indexed citations
14.
Morrow, David A., Eugene Braunwald, Marc P. Bonaca, et al.. (2012). Vorapaxar in the Secondary Prevention of Atherothrombotic Events. New England Journal of Medicine. 366(15). 1404–1413. 656 indexed citations breakdown →
15.
Bonaca, Marc P., Benjamin M. Scirica, Marc S. Sabatine, et al.. (2010). Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I. Journal of the American College of Cardiology. 55(19). 2118–2124. 103 indexed citations
16.
Scirica, Benjamin M., David A. Morrow, Andrzej Budaj, et al.. (2009). Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome. Journal of the American College of Cardiology. 53(16). 1411–1421. 39 indexed citations
17.
Wiviott, Stephen D., Eugene Braunwald, Dominick J. Angiolillo, et al.. (2008). Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38. Circulation. 118(16). 1626–1636. 498 indexed citations breakdown →
18.
Lewis, Eldrin F., Eric J. Velazquez, Scott D. Solomon, et al.. (2008). Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. European Heart Journal. 29(6). 748–756. 95 indexed citations
19.
Dalby, Anthony J., Brian G. Firth, & Robert Forman. (1981). Preoperative factors affecting the outcome of isolated mitral valve replacement: A 10 year review. The American Journal of Cardiology. 47(4). 826–834. 14 indexed citations
20.
Dalby, Anthony J. & Robert Forman. (1979). Acquired pulmonary stenosis.. BMJ. 2(6189). 512.2–513. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward T.A. Fry Breakdown of academic impact, for papers by David J. Moliterno Breakdown of academic impact, for papers by Piera Angelica Merlini Breakdown of academic impact, for papers by Jean‐Paul R. Herrman Breakdown of academic impact, for papers by Christian Valina Breakdown of academic impact, for papers by Jacques Quilici Breakdown of academic impact, for papers by George Kassimis Breakdown of academic impact, for papers by Bernardo Stein Breakdown of academic impact, for papers by Frederic Kontny Breakdown of academic impact, for papers by Mattía Galli
Rankless by CCL
2026